MIRA INFORM REPORT

 

 

Report Date :

23.01.2012

 

IDENTIFICATION DETAILS

 

Name :

MARICO LIMITED

 

 

Registered Office :

Rang Sharda Kishanchand Marg, Bandra Reclamation, Bandra (West), Mumbai – 400050, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

13.10.1988

 

 

Com. Reg. No.:

11-049208

 

 

Capital Investment / Paid-up Capital :

Rs.614.400 Millions

 

 

CIN No.:

[Company Identification No.]

L15140MH1988PLC049208

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchange.

 

 

Line of Business :

Manufacturer of Consumer Daily Products.

 

 

No. of Employees :

981 (Approximately), Group (2592)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (67)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

 

Maximum Credit Limit :

USD 35000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having fine track. Financial position of the company appears to be sound. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

 

 

 

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Dheeraj

Designation :

Accounts Department

 

 

LOCATIONS

 

Registered Office :

Rang Sharda Kishanchand Marg, Bandra Reclamation, Bandra (West), Mumbai – 400050, Maharashtra, India

Tel. No.:

91-22-66480480

Fax No.:

91-22-66490112/ 0114

E-Mail :

accounts@maricoindia.net

milinvrel@maricoindia.net

investor@mailcoindia.net

Website :

http://maricoindia.net

www.marico.com

www.kayaclinic.com

www.parachuteadvanced.com

www.saffolalife.com

www.haircodeworld.com

www.maricobd.com

www.maricoinnovationfoundation.org

Location :

Owned

 

 

Regional Offices :

Located At:

 

South Ro:

210-B, Swapanlok Complex, Sarojini Devi Road, Secunderabad – 500003, Andhra Pradesh, India

Tel No.: 91-40-27813351/ 55260067

 

West RO :

C-10, Dalia Industrial Estate, Modi House, Off. New Link Road, Near Fun Republic Cinema, Andheri (West), Mumbai – 400058, Maharashtra, India

Tel No.: 91-22-26732439-40/ 26732472

 

East Ro :

Krishna Building, 4th Floor, Room No. 416, 224, A.J.C. Bose Road, Kolkata - 700017, West Bengal, India

Tel No.: 91-33-22470750/ 22477629

 

North RO :

No.5, DDA Local Shopping Center, 3rd Floor, Okhla Commercial Complex, Phase II, New Delhi – 110020, India

Tel No.: 91-11-26383370/ 8167/ 8168

 

 

Factories :

Located At :

 

·         Daman

·         Deharadun

·         Goa

·         Jalgaon

·         Himachal Pradesh

·         Kerala

·         Pondicherry

·         Paonta Sahib

 

 

DIRECTORS

 

AS ON 31.03.2011

 

Name :

Mr. Harsh Mariwala

Designation :

Chairman and Managing Director

 

 

Name :

Mr. Nikhil Khattau

Designation :

Chairman and Managing Director

 

 

Name :

Mr. Rajeev Bakshi

Designation :

Director

 

 

Name :

Mr. Atul Choksey

Designation :

Director

 

 

Name :

Mr. Anand Kripalu

Designation :

Director

 

 

Name :

Mr. Rajen Mariwala

Designation :

Director

 

 

Name :

Ms. Hema Ravichandran

Designation :

Director

 

 

Name :

Mr. B.S. Nagesh

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mrs. Hemangi Wadkar

Designation :

Company Secretary

 

 

 

Management Team :

 

Name :

Mr. Harsh Mariwal

Designation :

Chairman and Managing Director

 

 

Name :

Mr. Saugata Gupta

Designation :

Chief Executive Officer - Consumer Product Business

 

 

Name :

Mr. Ajay Pahwa

Designation :

Chief Executive Officer – Kaya

 

 

Name :

Mr. Milind Sarwate

Designation :

Chief – Finance/ HR and Strategy

 

 

Name :

Mr. Vijay Subramanian

Designation :

Chief Executive Officer – International Business

 

 

 

Audit Committee :

 

Name :

Mr. Nikhil Khattu

Designation :

Chairman

 

 

Name :

Mr. Rajen Mariwala

Designation :

Member

 

 

Name :

Ms. Hema Ravichandar

Designation :

Member

 

 

Name :

Ms. Rachana Lodaya

Designation :

Secretary to the Committee

 

 

Name :

Mr. Harsh Mariwala

Designation :

Permanent Invitee

 

 

 

Corporate Governance Committee :

 

Name :

Ms. Hema Ravichandar

Designation :

Chairman

 

 

Name :

Mr. Rajeev Bakshi

Designation :

Member

 

 

Name :

Mr. Anand Kripalu

Designation :

Member

 

 

Name :

Mr. Milind Sarwate

Designation :

Secretary to the Committee

 

 

Name :

Mr. Harsh Mariwala

Designation :

Permanent Invitee

 

 

 

Shareholders Committee :

 

Name :

Mr. Nikhil Khattau

Designation :

Chairman

 

 

Name :

Mr. Rajen Mariwala

Designation :

Member

 

 

Name :

Ms. Rachana Lodaya

Designation :

Secretary to the Committee

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 31.12.2011)

 

Names of Shareholders

No. of Shares

Percentage of Holding

 

 

 

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Individuals / Hindu Undivided Family

83,662,520

13.61

Bodies Corporate

8,822,000

1.43

Any Others (Specify)

293,504,000

47.74

Trusts

293,504,000

47.74

Sub Total

385,988,520

62.78

 

 

 

(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

385,988,520

62.78

 

 

 

(B) Public Shareholding

 

 

(1) Institutions

 

 

Mutual Funds / UTI

24,358,127

3.96

Financial Institutions / Banks

90,000

0.01

Insurance Companies

5,473,693

0.89

Foreign Institutional Investors

158,557,544

25.79

 

 

 

Any Others (Specify)

3,000

-

Foreign Bank

3,000

-

Sub Total

188,482,364

30.66

 

 

 

(2) Non-Institutions

 

 

Bodies Corporate

14,871,411

2.42

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 Millions

19,929,324

3.24

Individual shareholders holding nominal share capital in excess of Rs.0.100 Millions

3,062,829

0.50

 

 

 

Any Others (Specify)

2,515,339

0.41

Clearing Members

137,371

0.02

Non Resident Indians

1,896,620

0.31

Trusts

80,168

0.01

ESOP/ESOS/ESPS

401,180

0.07

Sub Total

40,378,903

6.57

 

 

 

Total Public shareholding (B)

228,861,267

37.22

 

 

 

Total (A)+(B)

614,849,787

100.00

 

 

 

(C) Shares held by Custodians and against which Depository Receipts have been issued

-

-

(1) Promoter and Promoter Group

-

-

(2) Public

-

-

Sub Total

-

-

 

 

 

Total (A)+(B)+(C)

 

614,849,787

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Consumer Daily Products.

 

 

Products :

Product Description

 

Item Code No. (I.T.C. Code)

Coconut Oil

15131100

Sunflower Oil

15121910

Safflower Oil

15121930

 

 

GENERAL INFORMATION

 

No. of Employees :

981 (Approximately), Group (2592)

 

 

Bankers :

·         Axis Bank Limited

·         Barclays Bank PLC

·         Citibank N.A

·         HDFC Bank Limited

·         ICICI Bank Limited

·         Kotak Mahindra Bank Limited

·         Standard Chartered Bank

·         State Bank of India

·         HSBC Limited

 

 

Facilities :

Secured Loan

31.03.2011

(Rs. in

Millions)

31.03.2010

(Rs. in

Millions)

 

 

 

Secured Redeemable Non–convertible Debentures

Secured against first pari passu charge over land and building situated

at Andheri (East), Mumbai)

300.000

300.000

External commercial borrowings

(Secured by hypothecation of Plant and Machinery)

(Amount repayable within one year Rs 224.600 Millions (Rs 63.400 Millions))

390.100

617.600

Working capital finance

(Secured by hypothecation of stocks in trade and debtors)

2407.600

78.500

 

 

 

Total

3324.200

996.100

 

 

 

Unsecured Loan

 

31.03.2011

(Rs. in

Millions)

31.03.2010

(Rs. in

Millions)

From banks :

 

 

Short term

770.800

2432.200

Other term loans

950.000

0.000

Inter corporate deposits (Short term)

20.100

0.000

Commercial Papers (Redeemable within a year)

 

 

Face Value

950.000

350.000

Less : Deferred Interest

20.100

9.100

 

929.900

340.900

 

 

 

Total

 

2200.700

2773.100

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Price Waterhouse

Chartered Accountant

 

 

Internal Auditors :

Aneja Associates

Chartered Accountant

 

 

Subsidiaries :

Marico Bangladesh Limited

 

 

 

1) CPF International (Pty) Limited

(100% holding by Marico south Africa (Pty) Limited)

 

2) The DRx Clinic Pte. Limited

(100% holding by Derma – Rx International Aesthetics Pte. Limited ) w.e.f. May 25, 2010

 

3) The DRx Medispa Pte. Limited.

(100% holding by Derma – Rx International Aesthetics Pte. Limited.) w.e.f. May 25, 2010

 

4) DRx Investments Pte. Limited.

(100% holding by Derma – Rx International Aesthetics Pte. Limited.) w.e.f. May 25, 2010

 

5) DRx Aesthetics Sdn. Bhd.

(100% holding by DRx Investments Pte. Limited.) w.e.f. May 25, 2010

 

6) DRx Meditech Pte. Limited

(w.e.f. May 25, 2010 upto Feb 28, 2011 – merged with Derma – Rx International Aesthetics Pte. Limited. w.e.f. March 1, 2011)

 

7) Beauté Cosmétique Societé Par Actions

(99% holding by International Consumer Products Corporation) w.e.f. Feb 18, 2011

 

8) Thuan Phat Foodstuff Joint Stock Company

(87% holding by International Consumer Products Corporation) w.e.f. Feb 18, 2011

 

 

CAPITAL STRUCTURE

 

AS ON 27.07.2011

 

Authorised Capital: Rs. 2150.000 Millions

 

Issued, Subscribed & Paid-up Capital: Rs.614.850 Millions

 

 

AS ON 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

650000000

Equity Shares

Rs.1/- each

Rs. 650.000

Millions

150000000

Preference share

Rs.10/- each

Rs. 1500.000

Millions

 

 

 

 

 

Total

 

Rs. 2150.000

Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

614399550

Equity Shares

Rs.1/- each

Rs.614.400 Millions

 

 

 

 

 

 

The above includes:

 

·         290,000,000 equity shares issued as fully paid bonus shares by capitalisation of Capital Redemption Reserve.

·         265,000,000 equity shares issued as fully paid bonus shares by capitalisation of General Reserve

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

614.400

609.300

609.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

8116.800

5107.300

3068.500

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

8731.200

5716.600

3677.500

LOAN FUNDS

 

 

 

1] Secured Loans

3324.200

996.100

812.200

2] Unsecured Loans

2200.700

2773.100

2266.100

TOTAL BORROWING

5524.900

3769.200

3078.300

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

14256.100

9485.800

6755.800

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

2224.600

1299.700

1159.100

Capital work-in-progress

455.200

1099.500

456.000

Assets held for disposal

1.800

0.100

0.100

 

 

 

 

INVESTMENT

4703.600

2091.100

1125.800

DEFERREX TAX ASSETS

265.400

585.000

634.100

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

4542.200
3699.000

2736.900

 

Sundry Debtors

1189.800
945.100

610.500

 

Cash & Bank Balances

181.700
112.100

229.800

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

3295.700
2541.700

2062.300

Total Current Assets

9209.400
7297.900

5639.500

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

2025.200
2106.600

1786.300

 

Other Current Liabilities

258.800
158.500

163.800

 

Provisions

319.600
622.400

308.700

Total Current Liabilities

2603.900
2887.500

2258.800

Net Current Assets

6605.500
4410.400

3380.700

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

14256.100

9485.800

6755.800

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

23468.700

20242.900

19171.700

 

 

Income from Services

0.000

0.000

2.900

 

 

Other Income

251.700

220.600

145.300

 

 

TOTAL                                    

23720.400

20463.500

19319.900

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials

13643.000

10851.000

11570.300

 

 

Manufacturing and Other Expenses

6411.200

6251.700

5101.400

 

 

TOTAL                                    

20054.200

17102.700

16671.700

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

3666.200

3360.800

2648.200

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

299.200

183.000

289.200

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

3367.000

3177.800

2359.000

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

276.300

252.100

170.300

 

 

 

 

 

Add

EXCEPTIONAL ITEMS

(654.700)

0.000

(478.600)

 

 

 

 

 

 

PROFIT BEFORE TAX               

3745.400

2925.700

1710.100

 

 

 

 

 

Less

TAX                                                                 

592.200

575.500

289.100

 

 

 

 

 

 

PROFIT AFTER TAX                            

3153.200

2350.200

1421.000

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

3825.800

2331.000

1518.800

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

315.300

235.000

142.100

 

 

Debenture Redemption Reserve

166.700

150.000

0.000

 

 

Interim Dividend

66.400

402.100

398.900

 

 

Tax on Interim Dividend

405.400

68.300

67.800

 

BALANCE CARRIED TO THE B/S

953.800

3825.800

2331.000

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value

1391.600

1306.400

1251.400

 

 

Royalty

68.400

65.600

43.900

 

 

Dividend

44.800

46.900

20.600

 

 

Interest

40.300

44.100

22.100

 

TOTAL EARNINGS

1545.100

1463.000

1338.000

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

328.000

844.500

871.600

 

 

Packing Material

27.000

64.200

112.800

 

 

Capital Goods

1.600

5.000

24.800

 

 

Finished Goods for Resale

18.800

32.000

14.500

 

TOTAL IMPORTS

375.400

945.700

1023.700

 

 

 

 

 

 

Earnings Per Share (Rs.) (Basic)

5.13

3.86

2.33

 

Earnings Per Share (Rs.) (Diluted)

5.13

3.84

2.33

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

31.06.2011

30.09.2011

 

1st Quarter

2nd Quarter

Net Sales

8075.950

7183.390

Total Expenditure

7004.010

6219.370

PBIDT (Excl OI)

1071.940

964.020

Other Income

1071.940

100.710

Operating Profit

43.100

1064.730

Interest

1115.040

58.290

Exceptional Items

65.980

0.000

PBDT

0.000

1006.440

Depreciation

1049.060

75.370

Profit Before Tax

71.330

931.070

Tax

977.730

132.150

Provisions and contingencies

161.560

0.000

Profit After Tax

816.170

798.920

Extraordinary Items

0.000

0.000

Prior Period Expenses

0.000

0.000

Other Adjustments

0.000

0.000

Net Profit

816.170

798.920

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

15.78

11.48

7.35

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

15.95

14.45

8.92

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

32.75

34.03

25.15

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.42

0.51

0.46

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.93

1.16

1.45

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.53

2.53

2.50

 

 

 

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

REVIEW OF OPERATIONS
 
Marico achieved a strong growth of 18% in revenue over the previous year and registered a top line of Rs 31280.000 millions during FY11. A substantial part of the growth was organic growth, with 12% volume led  growth while the remaining came from price increases and sales mix. The top line increase was accompanied by a bottom-line growth of 24%, after  considering the impact of extra-ordinary / exceptional items. Profit  After Tax (PAT) including exceptional / extra-ordinary items during the  year was at Rs 2864.000 millions as against Rs. 2320.000 millions in FY10. The  financials for FY11 include certain exceptional items of Rs 4890.000 millions   (Rs 294.000 millions on account of write back of provision towards contingent  excise duty liability provided in FY10, Rs. 500.000 millions on account of profit  on sale of Sweekar intellectual property rights, Rs. 77.000 millions on account  of impairment of clinic assets in Kaya Limited and Rs 227.700 millions on  account of impairment of intangibles related to Fiancée business) while  the financials of FY 10 include certain exceptional items . The  exceptional items have been explained in detail in the Management  Discussion and Analysis, which is an integral part of this Report. Had  it not been for these items, the PAT for FY11 would have been Rs. 2563.000 millions, a growth of 6% over FY10 (extraordinary items excluded from the comparable figure in the previous year).

 

During the year, Marico extended its record of year on year quarterly growth.
 

 

Q4FY11 was on a Y-o-Y basis:
 
The 42nd consecutive Quarter of growth in Turnover and
 
The 46th consecutive Quarter of growth in Profits
 
The company has demonstrated steady growth on both the top line and bottom line. Over the last 5 years, they have grown at a Compounded Annual Growth Rate of 22 % and 27% respectively

 

 

CONSUMER PRODUCTS BUSINESS: INDIA

 

Parachute, Maricos flagship brand, continued to expand its franchise  during the year. Parachute coconut oil in rigid packs, the focus part  of its portfolio, grew by 8% in volume as compared to FY10. Coconut oil  category as a whole grew by 5% in volume as compared to FY10. The  volume growth have been lower than expected due to steep rise in the  input prices due to which the Company took the prices up of the  Products. Marico offers its consumers a basket of value added hair oils  for their pre-wash and post wash hair conditioning, nourishment and  grooming needs (Key brands being Parachute Advansed hair oil, Parachute  Advansed Cooling oil, Parachute Jasmine non sticky hair oil, Nihar  Naturals perfumed hair oil, Hair and Care nourishing non sticky hair oil,  Hair and Care Almond Gold and Shanti Badam Amla hair oil). During the  year, all Maricos hair oil brands recorded healthy growth and the  portfolio as a whole grew by about 23% in volume terms over FY10. Super  Premium edible oils brand Saffola grew by about 16% in volume terms  compared to FY10. These growths were aided by introduction of new products.

 

Marico has been constantly investing in a healthy pipeline of new products. During the year the company launched new prototypes.  These  included variants of Saffola Rice Arise (Basmati and Long grain) -  lower GI rice, Parachute Advansed Ayurvedic hair fall solution and  Parachute Advansed Body Lotion.

 

 

INTERNATIONAL FMCG BUSINESS

 

From a single digit share in FY05, about 23% of the groups turnover is  now contributed by Maricos International FMCG business.  Its key geographical presence is in Bangladesh, MENA (Middle East and North Africa), Malaysia, South Africa and Vietnam.   

 

Maricos South African subsidiary acquired the healthcare brand  Ingwe. Its product portfolio complements the existing healthcare  brand Hercules. In February 2011, Marico strengthened its entry into  the South East Asian region through the acquisition of International  Consumer Products in Vietnam.

 

During FY11, the companies international business recorded a turnover growth of 22% over FY10. Much of this growth was derived from consumer franchise expansion - about 19%, accompanied by price led growth of 8%.  However, this was impacted adversely by forex appreciation of 5%.  Political disturbance in the MENA region adversely effected the growth of the international business in Q4 of FY11.

 

Kaya is the first organized player in the segment of cosmetic  dermatology and now enjoys a large first mover advantage in the segment  in India. It now offers its technology led cosmetic dermatological  services through 103 clinics: 81 in India across 26 cities and 16 in  the Middle East, 2 in Dhaka and 4 clinics through Derma Rx in Singapore  and Malaysia.

 

During the year Kaya acquired Singapore based skin care solutions business Derma Rx. This gave Kaya an access to an advanced skin care  market in terms of a wide bouquet of products and technology capable of  being transported across geographies.

 

Kayas offering are in the nature of discretionary spends. They had seen a down turn in Kayas performance in FY10 due to some external and  internal factors. While external macro environment is picking up they had  identified customer retention and share of product sales as key issues  to be addressed internally during FY11. There were efforts put to  tackle these issues. Kaya has seen a reasonable success as a result of  these measures taken.

 

The overall experience with Kaya Skin care business has been  encouraging. This is a fairly young business- only 8 years since its  inception. They have already experienced, in a few accounting periods, profitability at both clinic level and regional level. Maricos belief  in the Kaya Business model is therefore intact, especially as they  perceive the long term opportunity in skin care solutions to be significant.

 

 

OTHER CORPORATE DEVELOPMENTS

 

ACQUISITION OF DERMA RX

 

Kaya Limited, Maricos wholly owned subsidiary delivering skin care solutions in India acquired the cosmetic dermatological business of the  Singapore based Derma Rx Asia Pacific Pte Limited (DRx AP). This  acquisition provides Kaya access to a range of highly efficacious skin  care products. These products are capable of being transported across  geographies. Some of these products have already been introduced in  India and are in the process of being introduced in the Middle East. They believe that it will help in increasing the share of products to total revenue of Kaya.

 

Acquisition of the Brand Ingwe Marico, through its wholly owned subsidiary, Marico South Africa (Pty)  Limited  acquired the brand Ingwe from South Africa based Guideline  Trading Company. The range comprises immuno boosters focused on the  ethnic consumer in South Africa. The acquisition of Ingwe brings in a  range of products that complements that of MSAs brand Hercules.

 

ACQUISITION OF THE INTERNATIONAL CONSUMER PRODUCTS (ICP)

 

Marico strengthened its foot hold in South East Asia by taking up 85% equity in International Consumer Products Corporation (ICP), one of the  most successful Vietnamese FMCG companies. ICP was founded, in 2001, by  Dr. Phan Quoc Cong and his partner. Its brands (X-Men, LOvite, Thuan  Phat and others) have a significant presence across personal care,  beauty cosmetics and sauces/ condiments categories. X-Men is a leading  player in the male grooming segment in Vietnam and is the 2nd Most  Trusted Personal Care brand in the country. With over 35% market share,  it leads the mens shampoo category. LOvite, the companys premium  cosmetics brand ranks amongst the top 5 premium cosmetics brands in  Vietnam

 

 

DIVESTMENT OF BRAND SWEEKAR

 

Marico divested its refined sunflower oil brand Sweekar to Cargill India private Limited (Cargill). This is in line with Companies focus towards wellness platform through Saffola and thus focusing on healthy edible oils and functional foods.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS :

 

In line with the requirements of the Listing Agreement with the Bombay Stock Exchange and National Stock Exchange, the Company has been reporting consolidated results taking into account the results of its subsidiaries. This discussion therefore covers the financial results and other developments during the period April 2010-March 2011, with respect to Marico Consolidated comprising Domestic Consumer Products Business under Marico Limited (Marico) in India, International Consumer Products Business comprising exports from Marico and the operations of its overseas subsidiaries and the skin care solutions business of Kaya in India and overseas. The consolidated entity has been referred to as’ Marico' or 'Group' or 'The Group' in this discussion.

 

Some statements in this discussion describing projections, estimates, expectations or outlook may be forward looking. Actual results may however differ materially from those stated on account of various factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Group conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.

 

 

INDUSTRY STRUCTURE, OPPORTUNITIES AND THREATS

 

India's Fast Moving Consumer Goods (FMCG) sector is estimated to be about INR 1300billion having shown an annual growth of about 11% per annum over the last decade. Robust growth in India's Gross Domestic Product (GDP), growing urbanization, evolving consumer lifestyles and increased income in rural areas are some of the key drivers of growth. The FMCG segment includes products like soaps, detergents, oral care, hair care and skin care products, food and beverages, oils and dairy products.

 

Opportunities are opening up for FMCG marketers in India in various household income segments. The affluent, comprising about 1% of the population, are willing to buy premium products for their emotional value or exclusivity. The upper middle class, comprising about 2% of the population, may aspire to emulate the affluent. These two segments are driving the fast growth of premium and masstige products. While they make up a small proportion of the consuming base in the country, their numbers are expanding rapidly and are expected to double over the next decade. The numbers in the middle class are expected to expand significantly over the next decade. Comprising about 11% of the population today, this segment is likely to grow to nearly 30% by 2020. These consumers are becoming more aware about products and their benefits and taking informed decisions. While price is important, the consumer also demands value. Finally, there is the Bottom of the Pyramid (BOP) opportunity in India. These consumers are largely rural, spending on essentials with very little demand for expensive lifestyle products. These markets have hitherto been poorly served owing to infrastructural constraints.

 

India's demographic dividend is highlighted by the fact that it has 17% of the world’s population and that half of these people are below the age of 25. With a median age of 25years, increasing numbers are joining the Indian workforce. Whereas China's dependency ratio bottoms in the next five years, for India it's likely to bottom out only in 2040.India's share in world consumer spending is set to increase from 1.9% in 2005 to 3.1% in2020. (Source: Technopak) Income in the hands of younger consumers with a higher propensity to spend, is providing buoyancy to the economy while opening up new categories in the FMCG space. With more women joining India's workforce, FMCG marketers are finding opportunities to introduce products in the convenience and health foods segments. While spending on women's personal care products is also becoming far more acceptable and guilt-free.

 

Rapid shifts in income profiles are leading to an evolution of product categories. At the higher income levels, there is a need for more sophistication and customization to individual tastes. Personal preferences also drive multiple brand purchases within households, unlike the earlier trend of using only a single brand or product. Therefore, marketers are introducing several variants of products to cater to a wider set of preferences. Products are also being segmented to cater separately to the needs of men, women and children. Mass customization is likely to intensify with FMCG players profiling potential buyers by attributes such as age, region, skin type and ethnic background.

 

Consumers are steadily shifting from low prices to a price-plus platform. They now tend to balance price with quality, convenience, consistency, innovation and shopping experience. The quality conscious consumer is willing to pay a premium for effective solutions, improved services and a superior experience. The focus of marketers is to provide consumers with a holistic solution for their needs in the form of a consolidated offering of various products and services.

 

India's FMCG market can be divided into two segments urban and rural. The urban segments characterized by high penetration levels and higher spending propensity of the urban resident as compared to his rural counterpart. The trend towards urbanization continues, with migration of rural citizens to urban areas. The number of urban towns has increased significantly, estimated at 53% over the last two decades.

 

Rural India accounts for 70% of India's population and is estimated to account for 56%of national income and 64% of expenditure. This market is seeing significant income growth and employment diversity for the first time in its history. Income derived directly from agriculture has reduced to around 40% with farmers often multitasking. However, the indirect dependence of the rural economy on agriculture is still high. Infrastructural investments in roads, railways and telecom have led to improved connectivity in rural India with a positive impact on growth, employment, education and health care. The Government’s initiatives such as National Rural Employment Guarantee Act (NREGA), other employment generation schemes, waiver of loans and managing minimum support prices of select agricultural output are resulting in higher disposable incomes and consumption trends in rural India. The most recent initiative of providing a Unique Identification Number (UID) will further strengthen the position of people living in rural areas. Rural markets comprise about 34% of the total FMCG market. In recent times, the growth rate has overtaken that of the urban markets. Category penetration, however, still remains low, providing significant headroom for growth. With organized FMCG players accessing these markets, rural consumers are becoming increasingly brand conscious. However affordability remains a challenge, giving rise to a large market for small size SKUs.

 

India is currently going through a socioeconomic change; the country is witnessing an expansion of existing markets and the creation of many new ones. The beauty products market is expected to grow by 15%-20% in the future as a result of the changing socio-economic status of Indian consumers, especially women. Better paying jobs and exposure to fashion and beauty trends in the developed world through television and other media have resulted in changing tastes and choices. Middle class women are more conscious of their appearance and are willing to spend more on enhancing it. Modernization has led to changing aspirations where the need to be considered good-looking, well-groomed and stylish has taken on a newfound importance. This has changed the mindset of saving for future. Accordingly, people are spending more on consumption. As a result, hair care and skin care products are expected to show healthy growth. Indian men are also becoming conscious about their appearance, creating a market for male grooming products. There is also an increased awareness about good health practices. Sedentary lifestyles and unhealthy habits have led to the rise of lifestyle-related diseases such as diabetes and heart problems. Increased awareness is leading to a demand for healthier products with lower calories, less sugar, lower glycemic index, higher nutritional content and higher fiber.

 

Though there has been a growth in modern retail format stores in India, a significant share of business is still generated through the ‘mom and pop’ store (kirana) format. With better infrastructure aiding access to the rural economy, it is likely that’ mom and pop’ stores will remain the chief point of interface of the FMCG companies with the retail consumer. Organized retail comprises about 5% of FMCG business, but is expected to grow rapidly and expand its share over the next few years, reaching 11%by 2015 and nearly 30% by 2020. The share of certain categories such as processed foods and beverages is expected to grow rapidly within organized retail. Several formats exist within organized retail such as hyper marts, supermarkets and cash-and-carry (wholesale).It is expected that formats will evolve and new formats may come up in the future. There has been a rise in private labels and these could provide tough competition, particularly to players that are not differentiated and relatively weaker brands. Organized retail is also expected to make investments in information technology to optimize supply chain efficiencies. This will also require strong backward integration with distributors and manufacturers.

 

India Incorporated is looking to grow inorganically. It is important to go global, not only to create multiple growth engines, but also to create reverse learning for the home market. The year gone by has seen a number of overseas acquisitions made by Indian FMCG companies. Also, the emerging economies in Asia and Africa have low-to-medium penetrations in some of the FMCG categories. This signifies considerable headroom for growth in themed-term. Favorable macro-economic factors, changing attitudes of the consumers and progressive policies of governments also make these markets attractive destinations. Typically, gestation periods .tend to be longer as one needs to go up the learning curve in a new market. Some of them also offer inorganic entry possibilities that can create access to mainstream distribution, manufacturing and talent. This can speed up one's learning curve as long as there is a strategic fit with the target.

 

 

RESULTS OF OPERATIONS AN OVERVIEW

 

Marico achieved a turnover of Rs. 31280.000 Millions during FY11, a growth of 18% over FY10.The volume growth underlying this revenue growth was healthy at 12%.

 

Profit after tax (PAT) for FY11 was 2860.000 millions, a growth of 24% over FY10. These results include the following items that are not strictly comparable with FY10. Each of these items is explained in detail in the Notes to the Consolidated Annual Financial Statements:

 

• Reversal of Excise Duty Provision of Rs. 294.000 millions made during FY10 towards contingent excise duty obligation in respect of dispatches of coconut oil in packs up to200 ml

 

• Profit on divestment of edible oil brand ‘Sweekar’ amounting to Rs.500.000 Millions 

 

• Impact of change in accounting estimates relating to revenue recognition in Kay amounting to Rs. 313.200 millions

 

• Impairment Provision impact of Rs.77.400 millions  as a result of impairment testing at clinic level at Kaya Skin clinics in India.

 

• Impairment of tangible and intangible assets relating to the business of Fiancée amounting to Rs.227.000 millions

 

• Amortization of Intangible assets (brands) held by overseas subsidiaries amounting to Rs.95.000 millions 

 

Also, there is an increase in depreciation by Rs. 30.900 Millions as a result of review of remaining useful life of certain assets at Kaya Skin clinics.

 

Similarly there were certain one-time items included in FY10 results which are not strictly comparable such as Write-off of Translation Reserve pertaining business amounting to Rs. 41.000 millions and closure costs of Kaya Life Centres amounting to Rs. 57.000 millions.

 

If these items were to be ignored, the Sales and PAT for the year under review would have been higher at Rs. 31570.000 millions, a growth of 19% over FY10, and Rs. 3000.000 millions, a growth of 15% over FY10, respectively.

 

Marico has kept up its track record of quarterly growth. Q4FY11 was in Y-o-Y terms, the:

 

• 42nd consecutive Quarter of growth in Turnover and

 

• 46th consecutive Quarter of growth in Profits

 

Over the past 5 years, the Sales and PAT have grown at a compounded annual growth rate of 22% and 27% respectively

 

 

FINANCE CHARGES

 

Financial charges include interest on loans and other financial charges. There is an increase in finance costs owing partly to an increase in the overall interest rate regime and partly on account of increased borrowings. Borrowings are higher primarily on account of the acquisitions of Derma Rx, Ingwe and shares in ICP as well as higher inventory owing to inflation in input costs.

 

 

OUTLOOK

 

• Fundamentals in place to leverage India growth story

• New product pipeline being made robust scalability a key objective

• Continued growth in international business, near term MENA environment uncertain

• Kaya India showing early signs of recovery

 

Marico will continue to focus on its long term strategic objectives, with a bias towards franchise expansion in its businesses. In coconut oils in India, they will aim to grow the market through low-unit size packs. They expect to achieve volume growth of 6% to8% per annum in the medium term. In hair oils in India, Marico will focus on share gain through introduction of differentiated and innovative products, providing specificity to consumers, accompanied by effective communication. Successful execution of this strategy is expected to result in annual volume growth of 15% to 17% over the next 2-3 years. The Company’s efforts in expanding rural reach is also expected to contribute towards franchise expansion in coconut oils and hair oils. Saffola is riding a trend in healthy living being adopted by the Indian consumer. The brand expects to continue to grow its basket of premium refined edible oil by about 15% in volume each year. In addition Marico plans to build a sizeable business in the healthy foods space by leveraging Saffola's health equity.

 

In the international consumer products business, Marico will focus on growing the categories where it has significant market share - coconut oil in Bangladesh and male hair grooming in MENA and Vietnam. They will complement the growth of Parachute Coconut Oil in Bangladesh with the introduction of other products. In South Africa, they will work on increasing share in key categories, and over the medium term expand their footprint to other parts of sub-Saharan Africa. In the immediate term, their approach in MENA will be cautious. However, their current penetration levels indicate positive long term potential in this market. Code 10 in Malaysia is expected to continue at a very healthy growth rate, albeit on a small base. In Vietnam, they will focus on the process of integration. The business is expected to grow in healthy double digits, though the bottom line may be modest owing to the conscious strategy of higher investments in advertising during the year.

 

The Kaya skin business in India is showing early signs of recovery, having posted growth at same clinic level in H2FY11. In the short term therefore, they will work on improving its revenue streams from the existing clinics in India and bring the business back on the growth track. They will continue to invest in new clinic growth through expansion in the Middle East. It has taken Kaya longer to achieve profitability than what they had earlier anticipated. The long-term attractiveness of the business, however, remains intact.

 

The medium to long-term outlook on all the three businesses remains positive. Marico will thus focus on strengthening the building blocks for future value creation - strong equities for its existing brands amongst its consumers, volume growths, robust new product pipelines and competitive supply chain effectiveness.

 

 

FIXED ASSETS:

 

·         Freehold land

·         Leasehold land

·         Buildings

·         Plant and machinery

·         Furniture and fittings

·         Vehicles

 

INTANGIBLE ASSETS:

 

·         Trademarks and

·         Copyrights

·         Computer software

 

 

BUSINESS DESCRIPTION

 

Subject is engaged in the business of branded fast moving consumer goods and branded services. The Company operates in two segments: consumer products and others. The Company’s consumer products include coconut oils, other edible oils, hair oils and other hair care products, male grooming products, fabric care products, healthy foods, soaps, health care products, female beauty care products. Others is engaged in skin care. In India, Marico manufactures and markets products under the brands include Parachute, Nihar, Saffola, Mediker and Manjal. In August 2010, Marico through its wholly owned subsidiary Marico South Africa (Pty) Limited (MSA) acquired the brand Ingwe from the South Africa-based Guideline Trading Company. In February 18, 2011, the Company acquired 85% interest in International Consumer Products Corporation (ICP). During the fiscal year ended March 31, 2011, Kaya Limited, Marico’s wholly owned subsidiary of Company acquired Derma Rx Asia Pacific Pte Limited (DRx AP). For the nine months ended 31 December 2010, Marico Limited's revenues increased 16% to RS23.99B. Net income increased 19% to RS2.15B. Revenues reflect an increase in income from Consumer Products division and higher revenue from other segment. Net income also reflects an increase operating margin, higher other income, the absence of exceptional items and a decline in interest expense. The company is engaged in the production of fast moving goods

 

 

 

PRESS RELEASE

 

ACCORD FINTECH (INDIA)


18 October 2011

 

India, October, 18 -- Marico Limited has informed BSE that November 11, 2011 has been fixed as the Record Date for the purpose of payment of First Interim Dividend.]Further, the date of payment of dividend will be November 25, 2011.

 

 

ACCORD FINTECH (INDIA)


18 October 2011

 

India, October, 18 -- Marico has informed that November 11, 2011 has been fixed as the record date for the purpose of payment of first interim dividend. Further, the date of payment of dividend will be November 25, 2011.The above information is part of the company's filing submitted to the BSE.

 

 

FINANCIAL EXPRESS (INDIA)


16 October 2011

 

Bangladesh, October, 16 -- Doulot Akter Mala

 

About 1200 large businesses will come under the new networking system of the National Board of Revenue (NBR) from January next as the tax authority has made installation of prescribed software mandatory replacing the existing one.

 

The businesses include banks, insurance, mobile phone operators, hotels, restaurants, manufacturing companies, shoe, plastic goods, chain shops, corrugated iron (cg) sheet, furniture, beverage, etc.

 

Those businesses have to buy the NBR prescribed complete software and have to customize it with their own system.

 

The NBR has made the rule mandatory for large businesses that pay VAT above Tk 5.0 million and above annually.

 

The NBR held a meeting recently to expedite selection of software companies who will prepare the software for companies. Bangladesh Association of Software and Information Services (BASIS) and all commissioners of the VAT wing attended the meeting.

 

"The NBR will form a committee to select some firms evaluating their expertise to prepare the software as per requirements of the tax authority. The big companies will have to buy it for their businesses," said a senior VAT official.

 

The NBR has stipulated .a 12-point eligibility criterion for the software companies to apply to the NBR for getting the task of developing the software.

 

He said the NBR has found an applicant company 'Innovia Technology Limited' possessing expertise to meet the criteria.

 

The official said the process of selection of companies should be geared up as it would need three months to prepare software and customize it with the respective company.

 

"It's time to expedite the matter if the NBR wants to implement it from first day of the next calendar year," he said.

He said some big companies have already installed software for maintaining their accounts but it is not a complete one to meet demands of the taxmen.

 

Although those companies have obtained permission from the NBR before installing it, they have to replace the software now following the new instructions came in the budget for current fiscal, he said.

 

"We have issued letter to the businesses to get preparation on installing the software," said a commissioner of VAT field office.

 

Mandatory rule on installation of Electronic Cash Register (ECR) will remain valid for small and medium shops while new software will be made mandatory from January 1, 2012 for large businesses, he said.

 

Head of corporate affairs of Marico Bangladesh Limited, Md Iqbal Chowdhury, welcomed the installation of new software saying that it would reduce manual interaction between taxmen and taxpayers.

 

"VAT is a complicated law. Businessmen have to take separate registration for separate transaction or businesses under a single wing," he said.

Uniform software can simplify system of accepting price declaration by taxmen, submission of Chalan (invoice) etc, he said.

 

"Businessmen now submit chalan in every 72 hours in VAT offices. Such manual interaction should be shifted into online system," he added.

 

Businesses can tag the new software with POS (point of sale) system.

 

 

MINT

13 OCTOBER 2011

 

Mumbai, Oct. 13 -- Consumer packaged goods companies are expected to post impressive earnings growth in the quarter ended 30 September driven by higher revenue on the back of modest volume growth and price increases.

 

A survey of six brokerages-ICICI Securities Limited, IDFC Securities Limited, Kotak Institutional Equities, Motilal Oswal Financial Services Limited, Prabhudas Lilladher Private Limited and Sharekhan Limited shows that analysts estimate profit growth of 7-17% and sales growth of 15-20%.

 

Margins, though, will continue to remain under pressure. While the average price of key inputs saw a sequential dip in the quarter, prices of most commodities were still higher over the year-ago period. For instance, the price of palm oil-a key input for Hindustan Unilever Limited (HUL) and Godrej Consumer Products Limited (GCPL)-was higher by 15% year-on-year (y-o-y). The price of copra, the key input for Marico LImited was higher by over 50% y-o-y, according to a 7 October report by Sharekhan.

 

"We expect the growth during the quarter to be a healthy mix of volume and value. In fact, we have chosen to focus on top line growth, even if it were to come at the cost of margins," said Milind Sarwate, group chief financial officer and chief human resources officer, Marico Limited.

 

To offset the pressure on margins, companies hiked prices, reduced advertisement expenses and cut operational expenses. "Hence, we expect margins to witness a slight respite in the quarter ending September on a quarter-on-quarter basis but remain pressurized on a y-o-y basis," said a 5 October ICICI Securities report.

 

However, it may not be easy for all companies to keep hiking prices or bring down advertising expenses any further given the intensifying competition and worries about discretionary spending in a slowing economy, analysts said.

 

Colgate Palmolive Limited, for instance, has adopted an aggressive pricing strategy to take on competition from HUL and Dabur. The toothpaste maker is also engaged in an advertising war, with its Colgate Sensitive Pro Relief pitched against GlaxoSmithKline Consumer Healthcare Limited's Sensodyne.

 

Aggressive pricing and the advertising war will act as a drag on the earnings growth of Colgate Palmolive, a 4 October report by Motilal Oswal said. "This also shows a glimpse of the competitive intensity and its impact if Procter and Gamble enters the mainstream toothpaste market," the report said.

 

Motilal Oswal expects ITC Limited to post 17% sales growth, driven by a 7% volume growth in cigarettes, and 20% net profit growth. HUL's sales are likely to grow 14% with Ebitda (earnings before interest, taxes, depreciation and amortization) margin expansion of 30 basis points to 13.9%. It's net profit is expected to grow by 13.1%. One basis point is one hundredth of a percentage point.

 

Marico is expected to report sales growth of 24% y-o-y, driven by price hikes of key products Parachute and Saffola, and profit growth of 12.5%, according to a 5 October Kotak Institutional Equities report.

The stock market has already factored a robust earnings season into share prices, analysts said.

 

The FMCG index has risen 7% so far this year as the benchmark equity index, the Sensex, has dropped 20% in the same period. At 26 times estimated earnings, the FMCG index is trading above its five-year historical price-earnings average of 23. For the quarter ended 30 September, the FMCG index fell 3.34%, compared to decline of 12.69% in the Sensex in the same period.

 

With price increases looking difficult, the outlook for consumer goods makers will depend on volume growth prospects and input costs, analysts said.

 

"Any guidance that companies provide on volume growth and commodity costs will be keenly watched," wrote Prabhat Awasthi and Nipun Prem of Nomura Financial Advisory and Securities (India) Private Limited in a 10 October note to clients.

 

"The December quarter will be better as the trends are positive and demand is good," said Ullas Kamath, deputy managing director, Jyothy Laboratories Limited, the maker of fabric whitener Ujala.

 

 

MEDIA RELEASE

 

Marico Records 26% Turnover growth Profit up 9% amidst strong volume growth of 14%

 

Marico Q2FY12 turnover of ~INR 9740.000 Millions (~USD 216.4 mio) showed a growth of ~26% over Q2FY11. A robust volume growth of ~14% in the domestic Consumer Products Business (despite price increases necessitated in H2FY11) helped achieve this healthy revenue growth. The Company continues to priorities its consumer franchise over its margins. This consumer-centricity enabled it to sustain robust volume growth despite inflationary pressures in India.

 

The Company continues to prioritise its consumer franchise over its margins. This consumer-centricity enabled it to sustain robust volume growth despite inflationary pressures in India. Profit after tax (PAT) for Q2FY12 was ~INR 780.000 Millions (~ USD 17.3 mio), a growth of ~9% over Q2FY11.

 

Over the years, Marico has focused on sustainable profitable growth. Q2FY12 is in Y-o-Y terms, the 44th consecutive Quarter of growth in Turnover and 48th consecutive Quarter of growth in Profits. The Board of Directors of Marico Limited at its meeting held on November 4, 2011 declared a first interim dividend of 30% on its equity share capital of ~INR 615.000 Millions.

 

Marico had issued a mid-quarter Information Update on September 14, 2011. Reference to that update will help better appreciation of this Information Update especially the Outlook. Marico’s strategies find an echo in the Success Guru- Brian Tracy’s- maxim- "The ability to discipline oneself to delay gratification in the short term in order to enjoy greater rewards in the long term is the indispensable prerequisite for success."

 

Turnover growth was witnessed across the Company’s three business units. The Indian Consumer Products Business grew by 44% in value and 14% in volume terms. Marico’s International business posted a growth of 19% after foreign exchange fluctuations and a business growth of 33%. The Kaya business collections on Same Store basis grew by 16%. Market shares continued to be healthy all across.

 

The Consumer Products Business in India (CPB) achieved a turnover of INR 6670.000 Millions (~USD 148.2 mio), a growth of about ~44% over Q2FY12. The Turnover growth reflected healthy demand and continued business momentum manifest in a volume growth of ~14% over Q2FY11.

 

 

The chief contributors towards this growth were:

 

• Equity of Marico’s brands that provided sufficient pricing power- as retail price increases were necessitated in H2FY11 owing to high inflation in input costs

• Steady growth in the coconut oils market

• Share gain in value added hair oils

• Expansion in Saffola’s franchise

 

 

Parachute, Marico’s flagship brand, recorded robust volume growth during the quarter. Parachute coconut oil in rigid packs, the focus part of its portfolio, grew by ~10% in volume as compared to Q2FY11. Small packs continued to drive growth.

 

The Saffola Oil franchise grew by ~11% in volume terms during Q2FY12 compared to Q2FY11. During the quarter, all Marico’s hair oils brands recorded healthy growth. The company’s hair oils in rigid packs volumes grew by ~26% over Q2FY11.

 

Marico’s hair oils franchise had achieved market share gains during FY11 and has continued to do so if the FY12 also. There has been a shift of around 160 basis points in Q2FY11 compared to Q2FY11. Its volume market share during the 12 months ended September 2011 was ~23.4% up from 17% about 5 years ago. These market shares gains have been achieved through providing consumers with specific solutions, product innovation, packaging restaging, participation in more sub-segments of the value added hair oils category and continued media support in some of the brands and penetrative pricing action in others.

 

Nihar Shanti Amla continues to gain market share on the back of disruptive pricing and achieved a volume market share of ~15.5% for the 12 months ended September 2011. Shares in September 2011 were even higher at ~18%.

 

Copra prices had seen an unprecedented increase in H2FY11, following which there has been a correction. The average market prices of copra in Q2FY12 were lower than the average prices during Q1FY12. However, on a Y-o-Y basis, the prices in Q2FY12 were still ~50% higher as compared to Q2FY11.

 

Marico has followed a judicious pricing policy, despite the equity consistently displayed by its brands. We strongly believe in the long term consumption story in the Indian Consumer market.

 

Hence, after taking significant price increases, Marico held the retail prices for almost 9 months to avoid too many price increases in a short time span. It also varied the degree of price increases s across its portfolio; so that the low unit price “recruiter” packs do not breach a certain price threshold. During Q2FY12, the company maintained its retail prices, thereby accepting the consequent contraction in margins as compared to Q2FY11.

 

Marico, after a successful prototype of Parachute Advansed Body Lotion in West Bengal, recently launched the product on a national basis. This is In line with the Company’s strategy to participate in the Beauty and Wellness space- in specific in Hair Care and Skin Care.

 

Marico’s International Business Group (IBG) encompasses Bangladesh, MENA (Middle East and North Africa), South Africa and South East Asia. It comprised ~23% of the Marico Group’s turnover in FY11. IBG sustained its growth journey clocking a turnover of INR 2410.000 Millions (USD 53.5 mio) during Q2FY12. This denotes a growth of ~19% after foreign exchange fluctuations and a business growth of 33% over Q2FY11 boosted by the acquisition of 85% equity in International Consumer Products in Vietnam in February, 2011.

 

Parachute Coconut Oil in Bangladesh clocked a market share of 69% in the total CNO market (including loose oil). Parachute continues to be amongst the top 5 most trusted brands (Source: Bangladesh Brand forum)

 

The overall environment in MENA (Middle East and North Africa) is relatively better but not without instances of sporadic protests and disturbances. Some of the territories that still face instability such as Libya, Yemen and Syria continue to face closure of operations. However, they comprise only about 5% of Marico’s business in the MENA region. In Egypt, the combined market share of Fiancée and Hair Code was held at ~57%. Hair Code has been restaged with a new visual identity and campaign.

 

The South African business continued its growth journey recording a strong double digit Y-o-Y growth over Q2FY11.

 

The business environment in Vietnam remained challenging during the quarter with high inflation of 11% and cost push in power and fuel. X-Men, a leading Men’s grooming brand saw an uptick in its market share to 41%. The integration of operations is on track. Marico’s Malaysian business continues to grow at a very healthy rate albeit on a small base. Code 10 has responded well to the brand restage and the renewed thrust to distribution.

 

Kaya Skin Care Solutions

 

Kaya now offers skin care solutions- its technology led cosmetic dermatological services and products- through 105 clinics: 82 in India across 26 cities, 17 in the Middle East and 2 in Bangladesh in addition to the 4 Derma Rx clinics and medispas in Singapore and Malaysia.

 

During Q2FY12, Kaya achieved a turnover of INR 662.000 Millions (~USD 14.7 mio). The Kaya business in India and the Middle East achieved same store collection growth of 16% over Q2FY11. Kaya has thus sustained the topline growth trend for the past 4 quarters on a same store basis.

 

The products from Derma Rx introduced in India continue to gain good traction and now constitute about 23% of the revenues from Indian operations compared to 16% Q2FY11. During Q2FY12, Kaya recorded a revenue growth of ~7% over Q2FY11 and made a loss before tax of INR 75.000 Millions (~ USD 1.7 mio).

 

Marico expects that in Kaya, the current phase of securing consumers and ensuring cost effectiveness will hold out for some time. This will keep Kaya in an investment phase for a few more quarters.

 

 

OUTLOOK

 

In the medium term, the Company will focus on strengthening the building blocks for future value creation - strong equities for its existing brands amongst its consumers, volume growths, robust new product pipelines and operational effectiveness. In the short run, we may not see any easing of the cost push. Margins are thus likely to remain under pressure. Increased retail prices may have some impact on volume growth given the overall squeeze on the consumers’ wallet. Saugata Gupta, CEO, Consumer Products Business expressed happiness at the results- “The CPB team has competently dealt with the discontinuous input costs scenario and come out with flying colours. We now have a much higher degree of strategic unity and clarity, about our portfolio choice and growth strategies. We are poised to reap over the long term the dividends of India’s Consumption Story.”

 

Vijay Subramaniam, CEO, International Business said-“We expect Marico’s International Business to overcome the odds of political and economic uncertainty and upheavals in its focus territories and grow in healthy double digits. IBG is well poised to continue its journey of sustainable profitable growth in the medium term” Ajay Pahwa, CEO Kaya was delighted - “Kaya skin business in India is showing early signs of recovery having posted growth at same clinic level for the 4th consecutive quarter. We believe that the building blocks for long term value creation by Kaya are getting into place.”

 

Milind Sarwate, Group CFO and CHRO highlighted Marico’s focus on the long term, saying “Long term success can be ensured only through stronger brands that have an indelible mark with the consumers. We have therefore chosen to prioritise expansion of consumer franchise over expansion of margins.”

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]             INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]             Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]             Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]             Record on Financial Crime :

               Charges or conviction registered against subject:                                                                   None

 

5]             Records on Violation of Anti-Corruption Laws :

               Charges or investigation registered against subject:                                                                None

 

6]             Records on Int’l Anti-Money Laundering Laws/Standards :

               Charges or investigation registered against subject:                                                                None

 

7]             Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]             Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]             Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]           Press Report :

               No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.50.33

UK Pound

1

Rs.77.97

Euro

1

Rs.65.31

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

67

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)         Ownership background (20%)                  Payment record (10%)

Credit history (10%)                 Market trend (10%)                                 Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.